Tabula Rasa Healthcare has a total of 23 patents globally, out of which 10 have been granted. Of these 23 patents, more than 91% patents are active. United States of America is where Tabula Rasa Healthcare has filed the maximum number of patents, followed by Europe and Mexico. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Tabula Rasa Healthcare.
Tabula Rasa Healthcare was founded in the year 2010. The Company designs and develops cloud-based healthcare software solutions. The Company offers data-driven technology and solutions that enable healthcare organizations to optimize medication regimens. As of April 2023, the market cap of Tabula Rasa Healthcare is $142.41 Million.
Do read about some of the most popular patents of Tabula Rasa Healthcare which have been covered by us in this article and also you can find Tabula Rasa Healthcare patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tabula Rasa Healthcare patent portfolio.
How many patents does the founder and the CEO of Tabula Rasa Healthcare have?
The founder and CEO Calvin H. Knowlton has 3 patents.
How many patents does Tabula Rasa Healthcare have?
Tabula Rasa Healthcare has a total of 23 patents globally. These patents belong to 6 unique patent families. Out of 23 patents, 21 patents are active.
How Many Patents did Tabula Rasa Healthcare File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Tabula Rasa Healthcare Applications Filed | Tabula Rasa Healthcare Patents Granted |
| 2022 | 1 | 4 |
| 2021 | 5 | 1 |
| 2020 | 2 | 2 |
| 2019 | 1 | – |
| 2018 | 6 | 2 |
| 2017 | 6 | – |
| 2014 | 1 | – |
| 2013 | – | 1 |
| 2011 | 1 | – |
How many Tabula Rasa Healthcare patents are Alive/Dead?
How Many Patents did Tabula Rasa Healthcare File in Different Countries?
Countries in which Tabula Rasa Healthcare Filed Patents
| Country | Patents |
| United States Of America | 9 |
| Europe | 3 |
| Mexico | 2 |
| Canada | 2 |
| China | 1 |
| Hong Kong (S.A.R.) | 1 |
| Japan | 1 |
| United Kingdom | 1 |
Where are Research Centres of Tabula Rasa Healthcare Patents Located?
The Research Centre for all the Tabula Rasa Healthcare patents is the United States of America.
What Percentage of Tabula Rasa Healthcare US Patent Applications were Granted?
Tabula Rasa Healthcare (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 5 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Tabula Rasa Healthcare patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Tabula Rasa Healthcare?
| Law Firm | Total Applications | Success Rate |
| Morgan Lewis & Bockius | 6 | 100.00% |
| Archer & Greiner | 1 | 100.00% |
| Hulsey | 1 | 100.00% |
10 Best Tabula Rasa Healthcare Patents
| Tabula Rasa Healthcare Patents | Title |
| US11361856B2 | Population-Based Medication Risk Stratification And Personalized Medication Risk Score |
| US10890577B2 | Treatment Methods Having Reduced Drug-Related Toxicity And Methods Of Identifying The Likelihood Of Patient Harm From Prescribed Medications |
| USD893524S1 | Display Screen With Graphical User Interface |
| US10720241B2 | Medication Risk Mitigation System And Method |
| US8392220B2 | Medication Management System And Method |
| US20230019434A1 | Population-Based Medication Risk Stratification And Personalized Medication Risk Score |
| US20210375486A1 | Population-Based Medication Risk Stratification And Personalized Medication Risk Score |
| US20210140944A1 | Treatment Methods Having Reduced Drug-Related Toxicity And Methods Of Identifying The Likelihood Of Patient Harm From Prescribed Medications |
| US20200342995A1 | Medication Risk Mitigation System And Method |
| EP4147246A1 | Population-Based Medication Risk Stratification And Personalized Medication Risk Score |
| EP3454912A4 | Treatment Methods Having Reduced Drug-Related Toxicity And Methods Of Identifying The Likelihood Of Patient Harm From Prescribed Medications |
| CN110022908B | Methods Of Treatment With Reduced Drug-Related Toxicity And Methods Of Identifying The Potential For Patient Harm Caused By Prescription Drugs |
| EU0056661380001S | Graphical User Interfaces |
| GB90056661380001S | Graphical User Interfaces |
| WO2022094088A1 | System And Method Of Processing Pharmaceutical Substance Data |
| WO2021226489A1 | Population-Based Medication Risk Stratification And Personalized Medication Risk Score |
| WO2017213825A1 | Treatment Methods Having Reduced Drug-Related Toxicity And Methods Of Identifying The Likelihood Of Patient Harm From Prescribed Medications |
| MX389003B | Treatment Methods That Have Reduced Drug-Related Toxicity And Methods For Identifying The Likelihood Of Harm Arising From Prescription Drugs To Patients. |
| MX2022000107A | Treatment Methods That Have Reduced Drug-Related Toxicity And Methods To Identify The Likelihood Of Harm Arising From Prescription Drugs To Patients |
| CA3178042A1 | Population-Based Medication Risk Stratification And Personalized Medication Risk Score |
| CA3024989A1 | Treatment Methods Having Reduced Drug-Related Toxicity And Methods Of Identifying The Likelihood Of Patient Harm From Prescribed Medications |
| JP7042256B2 | Therapies With Reduced Drug-Related Toxicities And Methods For Identifying Potential Patient Harm From Prescription Drugs |
| HK40005932A | Treatment Methods Having Reduced Drug-Related Toxicity And Methods Of Identifying The Likelihood Of Patient Harm From Prescribed Medications |